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Abstract
MicroRNAs (miRNAs) are short single-stranded RNA molecules that regulate gene expression. MiRNAs originate from large
primary (pri) and precursor (pre) transcripts that undergo various processing steps along their biogenesis pathway till they
reach their mature and functional form. It is not clear, however, whether all miRNAs are processed similarly. Here we show
that the ratio between pre-miRNA and mature miRNA forms varies between different miRNAs. Moreover, over-expression of
several factors involved in miRNA biogenesis, including Exportin-5, Drosha, NF90a, NF45 and KSRP, displayed bidirectional
effects on pre/mature miRNA ratios, suggesting their intricate biogenesis sensitivity. In an attempt to identify additional
factors that might explain the versatility in miRNA biogenesis we have analyzed the contribution of two hnRNP family
members, hnRNPH1 and hnRNPR. Knock-down or over-expression of these genes suggested that hnRNPR inhibits, whereas
hnRNPH1 facilitates, miRNA processing. Overall, our results emphasize that miRNA biogenesis is versatile.
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Introduction
MicroRNAs (miRNAs) are short (,22-nucleotide), endogenous,
single-stranded RNA molecules that regulate gene expression by
promoting RNA transcript degradation or translation inhibition of
target mRNAs. MiRNA genes are transcribed in most cases by
RNA polymerase II into primary miRNA transcripts (pri-miRNA)
[1]. After transcription the primary microRNA (pri-miRNA) is
cleaved by a complex called the microprocessor that contains
DROSHA and DGCR8 (DiGeorge critical region 8) as well as
additional proteins. DROSHA is an RNase III enzyme and
DGCR8 is a protein that is essential for miRNA processing (also
known as Pasha) [2]. The cleaved transcript, 70–110 nucleotide
long, is referred to as precursor miRNA (pre-miRNA). After
nuclear processing the pre-miRNA is exported to the cytoplasm by
Exportin-5 in a complex with Ran-GTP61 [3]. Once the pre-
miRNA is in the cytoplasm the RNase III protein Dicer cleaves off
the loop of the pre-miRNA and generates a roughly 22-nucleotide
miRNA duplex. The functional strand of the mature miRNA is
loaded together with Argonaute (Ago2) proteins into RISC
complex [4]. In principle, the miRNA duplex could give rise to
two different mature miRNAs. However, in a similar manner to
siRNA duplexes, only one strand is usually incorporated into
RISC and guides the complex to target mRNAs.
An increasing number of proteins are being discovered as
having key functions in miRNA maturation. For example, it has
been shown that nuclear factors, NF-90 and NF-45 can inhibit pri-
miRNA processing into pre-miRNA in the case of pri-let-7a and
pri-miR-21 [5]. The KH-type splicing regulatory protein, KSRP,
can serve as a component of both Drosha and Dicer complexes
and regulates the biogenesis of a subset of miRNAs. KSRP binds
with high affinity to the terminal loop of the target miRNA
precursors and promotes their maturation [6]. It was suggested
that the terminal loop is a pivotal structure where miRNA
processing ‘activators’ (for example, KSRP) function in a
coordinated way to convey proliferating, apoptotic or differenti-
ating cues into changes of miRNA expression. Trabucchi et al. [6]
suggested that KSRP is a key regulator of the processing of a
sizeable subset of miRNA precursors (miR-1, miR-15, miR-16,
miR-20a, miR-21, miR-26b, miR-27b, miR-106a, miR-125, miR-
196, miR-206 and let-7) on the basis of its high-affinity binding to
their terminal loop.
There are potentially additional factors involved in miRNA
biogenesis with yet unknown roles. The DGCR8 complex contains
11 proteins that were shown to be associated with it [7]. These
include hnRNPH1 and hnRNPR, both representing a subfamily
of ubiquitously expressed heterogeneous nuclear ribonucleopro-
teins (hnRNPs). The hnRNPs are RNA binding proteins that form
a complex with heterogeneous nuclear RNA [8]. These proteins
are associated with pre-mRNAs in the nucleus and appear to
influence pre-mRNA processing and mRNA stability and
transport. While all of the hnRNPs are present in the nucleus,
some seem to shuttle between the nucleus and the cytoplasm. The
hnRNP proteins R and H1 have distinct nucleic acid binding
properties and have three repeats of quasi-RRM domains that
bind RNAs [9]. hnRNPR has been demonstrated to be involved in
pre-mRNA splicing [10,11] and to enhance transcription [12].
hnRNPH1 has been demonstrated to act as a splicing factor
[13,14].
The process of miRNA biogenesis appears to be applied to all
miRNA species (excluding very few miRtrons; see [15]). However,
it is not clear whether additional regulatory mechanisms facilitate
or inhibit the production of miRNAs in various tissues and
whether these act on all miRNAs expressed by a given cell type. If
the rate of miRNA production in cells is similar to all miRNA
species, it is expected that the ratio between pre-miRNA and
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analyzed miRNA processing in HeLa cells on both the pre-
miRNA and mature miRNA levels and we tested the effect of
over-expression of factors involved in miRNA processing on an
array of miRNAs. Our results suggest that distinct miRNAs exhibit
differential sensitivity to over-expression of tested factors. In
addition we have identified two hnRNPs whose expression levels
differentially alter the processing of miRNAs. The differential
association of these hnRNPs with distinct pri-miRNA might
explain their flexible processing. Altogether, our results emphasize
the great processing versatility of distinct miRNAs during their
biogenesis pathway.
Materials and Methods
Quantitative/real-time PCR (qPCR)
The cDNA for the quantification of pre-miRNAs and mature
miRNAs was obtained from the same cells and RNA extracts
(High Capacity cDNA Reverse Transcription Kit, Applied
Biosystems, and miScript Reverse Transcription kit, QIAGEN,
respectively). Levels of transcripts were measured for both pre and
mature miRNAs by qPCR using the miScript SYBR Green PCR
kit (QIAGEN). Mature miRNA qPCR detection was performed
according to the manufactures’ protocol. The pre-miRNA qPCR
detection was performed according to the following protocol: 26
QuantiTect SYBR Green PCR Master Mix (12.5 ml); Forward/
Reverse Primer (10 mM; 1 ml each); template cDNA and RNase
free water (up to 25 ml). The cycle threshold (Ct) of each mature
and pre-miRNA in the control (cells transfected with GFP) was
subtracted from each sample that was trasfected with the different
plasmids in order to receive the change in expression level (DDct).
Fold changes were obtained by using the formula 2‘-(DDct).
Cell growth and transfection
HeLa cells (ATCC) were grown in DMEM supplemented with
10% FCS, and penicillin/streptomycin (Sigma). Cells were
transfected in 10 cm plates when the cells reached 75%
confluence. Plasmid DNA (5 mg) was transfected together with
15 ml of lipofectamin in Opti-MEM (Invitrogen). In addition to the
5 mg plasmid DNA, 100 ng of GFP containing plasmid was added
in order to measure transfection efficiency. Between 4–6 hours
after the transfection the medium was replaced and cells were
harvested 48 or 55 hr later. A fraction of the cells were analyzed
by Western blot to detect the expression of the transfected
constructs while the remainder was used for RNA extraction.
Western Blot
Cells were washed with PBS and centrifuged. Lysis buffer (Tris
0.1 M+NaCl 150 nM pH=7.4+1% NP40) and proteinase
inhibitors were added to the pellet and the cells were incubated
on ice for 10 min. After 10 min centrifugation, sample buffer was
added to the supernatant and the pellet was boiled for 3 min then
placed on ice. The samples were separated in a 10% polyacryl-
amide gel electrophoresis. For transfer to membrane a wet transfer
was performed using an assembly of nitrocellulose membrane
(Thermo Scientific/Pierce) and Whatmann paper. The transfer
was performed at 100v, 280 mAmp for 1 hr and 40 min. After
washes with PTW (PBS+20% Tween 20) membrane was blocked
with 10% milk for 30 min. The first antibody was added (rabbit
anti myc for Exportin-5, and mouse anti Flag for the rest of the
proteins) to PTW containing 0.5% BSA for 1 hr. The second
antibody (goat anti rabbit or donkey anti mouse) was added in
10% milk in PTW for 1 hr. Each step was separated by additional
washes with PTW. Finally, after several washes with PTW (10 min
each) ECL (Thermo Scientific/Pierce) was added for 5 min and
the membrane was exposed to film.
Gene expressing plasmids
Plasmids were obtained as follows: KSRP (pCMV-TAG2B-
KSRP) from Dr. Roberto Gherzi, Gene Expression Regulation
Lab, Experimental Oncology Istituto Nazionale Ricerca sul
Cancro (IST), Italy; Exportin-5 (pk-myc-exp5) from Dr. Ian G.
Macara, University of Virginia School of Medicine, USA; Drosha
(pck-Drosha) from Dr. Narry Kim, Seoul University, South Korea;
NF45 (pcDNA-Flag-NF45) and NF90a (pcDNA-Flag NF90a) from
Dr. Shuji Sakamoto, Laboratory of Molecular Biology, Science
Research Center, Kochi Medical School, Japan. Plasmids
expressing hnRNPH1 and hnRNPR were constructed as follows.
A Flag sequence was added to each reverse primer directed
towards the hnRNPH1 and hnRNPR genes in order to generate a
tagged protein. A Kozak sequence was added before the first ATG
of each forward primer in order to increase protein expression.
The amplified genes were inserted into the pcDNA3 plasmid
backbone under the CMV promoter.
RNA extraction
RNA was extracted from the cells using TRIzol reagent
(Invitrogen) according to the manufacturers’ instructions. Briefly,
1 ml of TRIzol was added to a 10 cm plate. The cells were
transferred to a 1.5 ml tube with 200 ml chloroform and
centrifuged for 10 min. After centrifugation, the clear aqueous
phase was transferred to a new tube with 0.5 ml Isopropanol and
centrifuged again. The RNA pellet was washed with 75% Ethanol.
All RNA samples were then treated with DNase I (New England
Biolabs) at 37u for 10 min following inactivation at 75u for 10 min.
An additional cleaning step with phenol was usually required in
order to remove any DNase or buffers left in the sample.
Knock-down of hnRNPH1 and hnRNPR
Twenty-four hours prior to transfection cells were plated such
that their confluence at the time of transfection will be 30–50%.
Each 10 cm culture dish was transfected using Lipofectamine
RNAiMAX Reagent (Invitrogen). RNAiMAX complexes were
prepared by adding 75 pmol siRNA duplexes in 1 ml Opti-MEM
and combined with 15 ml of Lipofectamine RNAiMAX that were
diluted in 1 ml Opti-MEM. The siRNA duplex-Lipofectamine
RNAiMAX complexes were added to each plate containing cells.
Cells were incubated with the siRNA for 48 hr. Medium was
changed after 4 hr. Subsequent siRNA transfection was performed
24 hr after the first one using the same protocol. For each
transfection against hnRNPH1 and hnRNPR there was a control
plate with scrambled RNA (the same amount as in the siRNA
samples). The siRNA experiments were carried out three times
each in triplicates.
Immunoprecipitation (IP)
Ten cm culture dish with HeLa cells were transfected with
5 mg of pcDNA3-hnRNPH1-Flag, pcDNA3-hnRNPR-Flag or
pcDNA3-Flag. After 48 hr cells were immunoprecipitated using
EZview Red Anti-Flag M2 Beads (Sigma). At the end of the
precipitation procedure, RNA was extracted using RNeasy Plus
Mini Kit (Qiagen). Reverse transcription was obtained using High-
Capacity cDNA Reverse Transcription kit (Applied Biosystems).
All IP experiments were performed three times with triplicates in
each experiment. Although the immuno-precipitation process is
supposed to precipitate only the Flag tagged proteins, nonspecific
binding occurs in all IP experiments.
MicroRNA Biogenesis
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The ratio between pre- and mature miRNA levels varies
for different miRNAs
During the miRNA biogenesis pathway pri-, pre- and mature
miRNAs are formed. It was previously suggested that during the
miRNA biogenesis pathway different isoforms may accumulate at
all three stages of miRNA development. In order to asses whether
this is true for miRNA biogenesis in HeLa cells, as well, we
measured the accumulating levels of ten miRNAs using quanti-
tative/real-time PCR (qPCR) (Table S1). We chose these
particular ten miRNAs based on the specificity and ability of the
qPCR method to detect them, and their relevance to cellular
function. For most miRNAs chosen mature levels were higher
than pre-miRNA levels indicating that at least in our chosen set
miRNAs have much higher mature than pre- levels while for one –
the opposite effect is observed. The fold difference between mature
and pre-miRNAs varies greatly among the miRNAs tested
suggesting that processing of miRNAs in HeLa cells fluctuate
significantly between different miRNAs allowing accumulation at
different maturation stages. We note that the primers designed for
each pre-miRNA can amplify both the pre-miRNA and the pri-
miRNA. Therefore, the levels of pre-miRNA obtained using this
method represent both forms. Our result so far suggest that
miRNA biogenesis in HeLa cells is versatile for different miRNAs.
Given that all miRNAs are potentially exposed to the same cellular
factors, such differential regulation could result from their
sensitivity to the different miRNA biogenesis factors expressed in
HeLa cells.
Differential effect of miRNA biogenesis factors on miRNA
processing
In order to test whether any of the miRNA biogenesis factors
are accountable for the observed differential levels of pre- and
mature miRNA forms we over-expressed the following known
miRNA biogenesis pathway genes: (i) Drosha, which cleaves the
pri-miRNA into the pre-miRNA form of all but very few
exceptional miRNAs; (ii) Nuclear factors NF90a and NF45, which
inhibit the cleavage of pri-miRNA to pre-miRNA (shown for pri-
let-7a and pri-miR-21) [5]; (iii) KSRP, which binds the terminal
loop of the precursor and enhances its maturation (shown for miR-
1, miR-15, miR-16, miR-20a, miR-21, miR-26b, miR-27b, miR-
106a, miR-125, miR-196, miR-206 and let-7 on the basis of its
high-affinity binding to their terminal loop) [6]; (iv) Exportin-5,
which exports the pre-miRNA from the nucleus to the cytoplasm
[3]. After allowing high levels of these proteins to accumulate in
the cells (Fig. 1; 48 hr after transfection), RNA was extracted and
the levels of pre- and mature miRNAs were quantified relative to
control plasmid transfection.
Analysis of pre-miRNA and mature miRNA levels of over-
expressing Drosha cells showed that in eight out of the ten
miRNAs (miR-106b, miR-185, miR-193b, miR-196b, miR-21,
miRNA-224, miR-23b, and miR-25), both the mature and pre-
miRNA forms were decreased (Fig. 2A). In two out of the ten
miRNAs (miR-34a and miR-621) the levels of the mature miRNA
were elevated. In the case of miR-34a the pre-miRNA levels were
unchanged whereas in the case of miR-621 the pre-miRNA levels
decreased by two-fold. Increasing the levels of Drosha was
expected to increase mature levels as a result of more rapid or
efficient processing from pri- to pre-, however only two miRNAs
(miR-34a and miR-621) showed this tendency.
Analysis of pre and mature miRNA levels of over-expressing
NF90a and NF45 cells showed that in four out of the ten miRNAs
(miR-185, miR-21, miR-23b and miR-34a), the pre-miRNA levels
were elevated or unchanged whereas the mature levels were
decreased (Fig. 2B). Three out of the ten miRNAs (miR-106b,
miR-224 and miR-25) showed decreased levels of both mature and
pre-miRNA forms. The remaining three miRNAs (miR-193b,
miR-196b and miR-621) exhibited elevated mature levels and
decreased pre-miRNA levels. Nuclear factors 90a and 45 (NF90a/
45) were previously shown to inhibit the processing from pri- to
pre-miRNA of pri-let-7a and pri-miR-21 [5]. Therefore, increas-
ing their levels is expected to result in decreased mature levels and
elevated/unchanged pre-miRNA levels. Indeed four of the ten
miRNAs showed this tendency whereas the other six miRNAs
showed other trends (Fig. 2B).
Analysis of pre- and mature miRNA levels of over-expressing
KSRP cells, previously shown to promote the transition from pri
to pre for several miRNAs, indicated that seven out of the ten
miRNAs (miR-106b, miR-193b, miR-196b, miR-21, miR-224,
miR-23b and miR-25) showed a variable decrease in the levels of
both pre and mature forms (Fig. 2C). Two miRNAs (miR-185 and
miR-34a) exhibited an increase of pre-miRNA levels, one – a slight
decrease (miR-185) and the last – no change (miR-34a) in mature
levels. One miRNA (miR-621) showed an increase in mature levels
and a decrease in pre- levels. Interestingly, miR-106b, miR-185,
miR-224, miR-25, miR-34a and miR-621 showed the same
Figure 1. Expression levels of factors involved in miRNA biogenesis. Western blot analysis using (A) anti-myc antibody or (B) anti-Flag
antibody of HeLa cells over-expressing either (A) Exportin-5, (B) Drosha, KSRP or NF-90a and NF-45.
doi:10.1371/journal.pone.0019391.g001
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that these factors affect them in a similar way. NF90 and KSRP
are both translation regulatory RNA-binding proteins [16].
Over-expression of Exportin-5 led to significant shifts in the
levels of pre- versus mature miRNAs. For six out of the ten
miRNAs (miR-193b, miR-196b, miR-21, miR-224, miR-23b and
miR-25), both the mature and the pre-miRNA forms were
decreased (Fig. 2D). In three out of the ten miRNAs (miR-106b,
miR-185 and miR-34a), the levels of the pre-miRNAs were
elevated whereas the levels of the mature were decreased. One
miRNA (miR-621) showed an increase in mature levels and no
change in the pre levels. Over-expression of Exportin-5 was
expected to facilitate the levels of mature miRNAs due to a more
rapid or efficient export of the pre-miRNA from the nucleus to the
cytoplasm. Interestingly, only one miRNA (miR-621) showed this
tendency, namely an increase in mature levels whereas all the rest
showed a decrease in mature levels.
In summary, our results suggest that even though miRNAs are
potentially exposed to the same cellular factors their biogenesis is
individually and intricately regulated. This also suggests that the
binding of miRNA biogenesis factors to the assembling miRNA
transcript might be a regulatory step controlling the levels of the
different miRNA forms.
hnRNPH1 and hnRNPR bind the pri-miRNA transcripts
We have shown that miRNA biogenesis factors, known to bind
miRNA transcripts during their maturation process, affect miRNA
levels distinctively. In an attempt to identify additional genes that
would explain the variability in the processing of the ten miRNAs
analyzed in our study, we decided to focus on the function of two
candidate RNA binding proteins (RNPs); hnRNPH1 and
hnRNPR. These RNPs are part of 11 proteins that have been
shown to be associated with the DGCR8 complex and in addition
they are known to be involved in RNA processing [7]. To address
whether these RNPs exert their affect directly or via mediators we
performed immunoprecipitation experiments asking whether pre-
miRNAs are bound to hnRNPH1 or hnRNPR proteins. Following
successful immunoprecipitation of these proteins (note that
negative control Flag-only peptides were not precipitated; Fig. 3),
RNA was extracted from the precipitates and the levels of pri-
miRNAs were analyzed using qPCR. We interpreted the amount
of each pre-miRNA as the affinity by which it was bound to its
precipitated protein. The miRNAs were divided into three groups
– low, medium and high association with the hnRNPs –
representing different degrees of affinity, according to the amount
of pri-miRNA versus the negative control vector (Table 1) (see Fig.
S1 for an additional negative control). We further segregated the
detected pri-miRNAs in each sample into three groups. In the first
group the fold changes of the pri-miRNA levels relative to control
were low (x1–3). In the second group the fold changes of the pri-
miRNA levels relative to control were intermediate (x3–6). While
in the third group the fold changes of the pri-miRNA levels
relative to control were high (x6 and up) (see Table S2).
Interestingly, the pri miRNAs showed different affinities to the
two proteins. For example, pri-miRNA-34a showed a high affinity
towards hnRNPH1 but only a medium affinity to hnRNPR
whereas pri-miRNA-21 had a low affinity towards hnRNPH1 and
a medium affinity towards hnRNPR. To exclude the possibility
Figure 2. Fold change levels of mature and pre-miRNAs in transfected HeLa cells. Fold change levels of mature and pre-miRNAs in cells
over-expressing (A) Drosha, (B) NF90a and NF45, (C) KSRP, or (D) Exportin-5.
doi:10.1371/journal.pone.0019391.g002
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total amount of pri/pre-miRNA in the cell, the levels of the pre
(and pri) miRNA in untreated cells were measured (Fig. S2). The
results clearly demonstrated that there is no correlation between
the amounts of a given pre/pri miRNA in the cell and the ability
of the RNPs to precipitate it. For example, pri-miR-621 exhibits
the highest levels of pre-miRNAs in the cell but it only shows a
medium affinity to both RNPs. Pri-miR-34a is one of the least
abundant miRNAs (Fig. S2) however it exhibits a high affinity to
the hnRNPH1 protein. It is thus most likely that the co-
immunoprecipitation experiments correspond to a genuine affinity
of the pri-miRNA to the hnRNPs. These results demonstrate that
both hnRNPs form protein-RNA complexes with distinct pri-
miRNAs, and thus hnRNPH1 and hnRNPR are directly involved
in the processing of miRNAs.
Reduction of hnRNPH1 and hnRNPR levels changes
miRNA processing
We have shown using immunoprecipitation experiments that
hnRNPR and hnRNPH1 bind pri-miRNAs. In order to see
whether these proteins exhibit a direct effect on miRNA
biogenesis, we analyzed miRNA processing following their over-
and under-expression. hnRNPH1 and hnRNPR mRNA levels
were significantly reduced in HeLa cells by 5 and 7 fold,
respectively (Fig. 4A). Analysis of pre and mature levels of cells
with reduced hnRNPR amounts exhibited that all mature
miRNAs levels have increased (miR-34a, miR-621, miR-21,
miR-185, miR-196b, miR-224 and miR-23b) or have remained
unchanged (miR-193b, miR-106b and miR-25) (Fig. 5A). This
finding suggests that hnRNPR may have an inhibitory role in the
miRNA biogenesis pathway and therefore reducing its levels
resulted in increasing levels of many of the miRNAs. Pre-miRNAs
levels mostly remained unchanged or have slightly increased. The
phenomenon was robust and persisted at various gene knock-out
levels, cell confluence and time periods (data not shown). Analysis
of pre and mature miRNA levels in cells with reduced hnRNPH1
mRNA amounts exhibited an increase of pre-miRNA levels in
eight out of the ten miRNAs (miR-34a, miR-21, miR-185, miR-
193b, miR-106b, miR-224, miR-23b and miR-25) (Fig. 5B). This
finding suggests that hnRNPH1 may have a positive role in the
miRNA biogenesis pathway and therefore reducing its levels might
result in increased levels of most pre-miRNAs. One pre-miRNA
level was decreased (miR-196b) while another was unchanged
(miRNA-621).
Over-expression of hnRNPH1 and hnRNPR changes
miRNA processing
Both hnRNPH1 and hnRNPR showed a dramatic, yet opposite,
effect on miRNA biogenesis of the ten miRNAs examined. In
order to test whether this phenomenon is reversible we over-
expressed these genes (Fig. 4B) and looked at pre- and mature
miRNA levels. Over-expression of hnRNPR led to a decrease in
the levels of mature miRNAs (miR-34a, miR-21, miR-185, miR-
106b, miR-196b and miR-224) or did not change their levels
(miR-621, miR-193b, miR-25 and miR-23b) (Fig. 5C). The pre-
miRNA levels have remained the same for nine out of the ten
miRNAs. Pre-miRNA-193b exhibited increased levels by two fold.
These results support the possible inhibitory role of hnRNPR on
miRNA processing. Analysis of pre- and mature miRNA levels in
over-expressing hnRNPH1 cells showed that all pre- and mature
miRNAs have remained unchanged (Fig. 5D).
Discussion
In our study we showed that different types of miRNAs are
processed in different manners in HeLa cells. Moreover, the
sensitivity of each miRNA to over-expression of general factors
involved in miRNA biogenesis differs significantly. Importantly,
we have identified two hnRNP proteins, hnRNPH1 and
hnRNPR, that are associated with pri-miRNAs and influence
their processing in HeLa cells. Furthermore, we showed that
hnRNPR exhibits an inhibitory role in miRNA processing while
hnRNPH1 functions to facilitate miRNA processing. Although
these proteins were described to be part of the DGCR8 complex
we have demonstrated, for the first time, their involvement in
miRNA processing. The sensitivity of the miRNAs to depletion or
Figure 3. Western blot analysis performed on immunoprecip-
itated hnRNPR and hnRNPH1. Western blot analysis with anti Flag
antibody performed on samples immunoprecipitated with anti-Flag M2
beads. The band that appears in all three samples around 50 kDa
represents the heavy chain of the IgG.
doi:10.1371/journal.pone.0019391.g003
Table 1. Degrees of binding affinity of pri-miRNAs to
hnRNPH1 and hnRNPR proteins following
immunoprecipitation.
Binding of protein
to pri-miRNAs hnRNPH1 hnRNPR
miR\Binding Low Medium High Low Medium High
pri-miR-34a ++
pri-miR-621 ++
pri-miR-21 ++
pri-miR-185 ++
pri-miR-193b ++
pri-miR-106b ++
pri-miR-196b ++
pri-miR-224 ++
pri-miR-23b ++
pri-miR-25 ++
The extent of binding of hnRNPR and hnRNPH1 to the 10 selected miRNAs.
doi:10.1371/journal.pone.0019391.t001
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miRNAs.
The difference in the levels of mature and pre-miRNA
forms
Our results suggest that the ratio between mature and pre-
miRNA forms differ between distinct miRNA types. The data
obtained in our experiments implied that there is variability in the
rate of processing between different miRNAs in HeLa cells. We
chose ten miRNAs based on the specificity and accuracy of the
qPCR method to detect them, and their relevance to cellular
function, for further analysis. The group of miRNAs we chose to
further analyze includes miR-21 which acts as an oncomir in
prostate and other cancers (for example see [17] and the miR-
106b-25 miRNA cluster which has a role in hepatocellular
carcinoma [18]). The qPCR analysis clearly demonstrated that in
nine out of the ten miRNAs analyzed the mature miRNA levels
were significantly higher than the pre-miRNA levels. This
observation could be interpreted by two alternative explanations:
(i) the half-lives of these mature miRNAs are high and therefore
Figure 4. Fold change and expression of hnRNPR and hnRNPH1 following their knock-down or over expression. (A) Fold change levels
of hnRNP mRNAs in cells following knock-down with siRNA for 48 h. (B) Western blot analysis using anti-Flag antibody of HeLa cells over-expressing
hnRNPH1 and hnRNPR.
doi:10.1371/journal.pone.0019391.g004
Figure 5. Fold change levels of mature and pre-miRNAs in HeLa cells in which hnRNPs were knocked down or over expressed. Fold
change levels of mature versus pre-miRNAs in cells following knock-down of (A) hnRNPR or (B) hnRNPH1 by siRNA for 48 h and following over-
expression of (C) hnRNPR or (D) hnRNPH1.
doi:10.1371/journal.pone.0019391.g005
MicroRNA Biogenesis
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of these miRNAs is high, meaning that the transition rate from
pri/pre forms to mature miRNA is rapid. One miRNA (miR-621)
showed an opposite tendency. The pre levels were high while its
mature levels were relatively low. This could be explained by the
fact that: (i) the pre-miRNA is very stable; (ii) the processing rate of
this miRNA from pri/pre form to mature miRNA is slow which
means that most of the miRNA is left in its pri/pre form. In both
cases we do not have information about the rate of transcription
for these miRNAs which could be an additional factor affecting the
changes observed in the ratio between mature and pre-miRNA for
the different miRNA types. These results are consistent with the
hypothesis that different miRNA types are processed at a
differential rate.
The effect of over-expression of factors involved in
miRNA processing on the levels of mature and pre-
miRNAs
To asses whether the different processing rates of the miRNAs
occur due to their differential sensitivity to the levels of known
biogenesis factors, we over-expressed several of them in HeLa cells
and analyzed the levels of pre- and mature miRNAs. The factors
tested included: Exportin-5, Drosha, NF90a/NF45 and KSRP. All
the genes were expressed at high levels (as indicated by Western blot
analysis, except NF45 which exhibited a low expression level, at least
5 fold). Although it has been shown that the maximum effect on
miRNA processing occurs when both NF90 and NF45 are
transfected together, NF90 exhibited an effect on miRNA processing
when over-expressed alone [5], therefore the relatively low levels of
NF45werenotexpectedtoaffecttheresultsinaquantitativemanner.
Exportin-5 over-expression
Over-expression of Exportin-5 was expected to increase the
levels of mature miRNAs [3] but instead in nine out of ten
miRNAs the levels of the mature miRNA were decreased. Only
miR-621 showed an increase in mature levels as expected. Possible
explanations for the fact that most miRNAs did not show an
increase in mature levels are: (i) that the pre-miRNA levels were
low at the beginning of the experiment, over-expression of
Exportin-5 would not change mature levels because there would
be no excess pre-miRNA to export from the nucleus; (ii) it was
shown that Exportin-5 contributes to the stability of the pre-
miRNA. It might be possible that over-expression of Exportin-5
stabilized the pre-miRNA forms to such degree that it prevents
further processing and therefore lead to a decrease in the mature
levels [3]; (iii) Exportin-5 levels in the cells are saturated; (iv) an
excess of Exportin-5 could associate with other factors which lead
to their exclusion from the nucleus and to reduced miRNA
biogenesis activity. For example, binding of an excess of Exportin-
5 to GTP could decrease GTP levels in the nucleus and therefore
slow the export process instead of increasing it. The only miRNA
that showed elevated mature levels in response to over-expression
of Exportin-5 was miR-621. Possible explanations for this
observation are: (i) miR-621 exhibits very high pre-miRNA levels
and therefore elevated Exportin-5 indeed facilitated its export to
the cytoplasm promoting its maturation; (ii) this miRNA exhibits
unique affinity to Exportin-5 which takes first priority in export
over the other miRNAs; (iii) the half-life of the mature miRNA is
longer for miR-621.
Drosha, NF90a, NF45 and KSRP over-expression
Over-expression of Drosha, an enzyme that is involved in the
pri to pre-miRNA processing, increased mature levels of two out of
the ten miRNAs. This was in contrast to the expected effect of
increased mature miRNA levels. Only miR-34a and miR-621
showed subtle elevated mature levels. Interestingly, pre- levels of
most miRNAs decreased by two-fold. Possible explanations for
these observations are: (i) Drosha works with DGCR8 which was
not over-expressed in this experiment. If DGCR8 is a limiting
factor then Drosha alone would not have a strong impact on
miRNA processing; (ii) an excess of Drosha could deplete other
factors that usually work in concert with the complex. This could
result in accumulation of pre-miRNAs. It was shown that the
complex of Nuclear Factor 90 (NF90) and NF45 proteins functions
as a negative regulator in miRNA biogenesis in the case of pri-let-
7a and pri-miR-21 [5]. For these miRNAs, pri-miRNA processing
into pre-miRNA was inhibited by over-expression of the NF90
and NF45 proteins. In our experiments, over-expression of NF90a
and NF45 promoted a decrease in mature levels in four out of the
ten miRNAs. One miRNA, miR-21, was also affected in the
Sakamoto study [5] and shows consistency with their observation.
These results suggest that NF90a and NF45 might influence the
processing of a subgroup of miRNAs. MiR-621 showed an
opposite tendency relative to the rest of the miRNAs in response to
over-expression of NF90a and NF45. It is possible that this
miRNA utilizes a different processing pathway. KSRP facilitates
the transition between pri and pre forms for some miRNAs [6].
Therefore over-expression of KSRP is expected to elevate mature
miRNA levels. However, only miR-621 showed this tendency.
This could be due to the fact that KSRP works on some but not all
miRNAs. In addition, an increase in the transition between pri
and pre-miRNA levels may not result in an automatic increase in
the mature miRNA levels due to additional factors involved along
the pathway.
The involvement of hnRNPR and hnRNPH1 in miRNA
biogenesis
Although it was shown that hnRNPH1 and hnRNPR are part
of the DGCR8 complex, their direct involvement in the miRNA
processing pathway has not been investigated.
In order to asses whether the effect of hnRNPR is direct and
depends on the ability of hnRNPR to be in association with a
given pri-miRNA, we performed immunoprecipitation experi-
ments of protein-RNA complexes. The results show that the
binding of hnRNPR to the pri-miRNAs was specific; however the
affinity of the binding varied between the miRNAs. In certain
cases there is a correlation between the ability of the protein to
bind a certain pri-miRNA and its ability to affect miRNA
processing following knock-down by siRNA (miR-106b, miR-25,
miR-196b, miR-21, miR-621 and miR-34a), suggesting that
hnRNPR acts in a way that depends on its affinity to the pri-
miRNA (Fig. S3). In addition, some miRNAs that were elevated
following knock-down of hnRNPR were decreased following its
over-expression (miR-25, miR-196b, miR-21, miR-621 and miR-
34a). However, additional factors might influence its inhibitory
activity explaining cases in which there was no correlation between
the binding affinity and the activity of this protein.
In order to test for a more direct involvement of these proteins
in miRNA biogenesis, we have knocked-down their levels in HeLa
cells. The knock-down at the mRNA level was highly efficient and
decreased their levels significantly (Fig. 4).
hnRNPR exhibits an inhibitory effect on miRNA
maturation
Reducing hnRNPR levels led to an increase in mature miRNA
levels of seven out of ten miRNAs examined. The pre levels mostly
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mature levels suggests that hnRNPR has an inhibitory role in
miRNA processing and therefore knocking-down its levels led to
an increase in miRNA processing. Possible explanations for
hnRNPR inhibitory activity might be its binding to the pri-
miRNA and inhibiting its further processing by Drosha or causing
its destabilization. Consistent with the idea that hnRNPR plays an
inhibitory role; over-expression of this protein in HeLa cells caused
a decrease in most of the mature miRNAs. However, there was
variability in the response of the miRNAs to the over-expression of
hnRNPR. Significantly, most miRNAs that responded positively
to the siRNA of hnRNPR decreased their levels in response to
over-expression of hnRNR, suggesting that hnRNPR is necessary
and sufficient for inhibiting miRNA processing in the tested group
of miRNAs. Two miRNA (miR-25 and miR-193b) did not
respond to either of the transfections, suggesting an independent
or different processing pathway that may not involve hnRNPR.
hnRNPH1 might promote miRNA processing
Knock-down of hnRNPH1 caused variable effects. The pre-
miRNA levels in most miRNAs showed an increase suggesting a
positive role for hnRNPH1 in miRNA processing. Two miRNAs,
miR-196b and miR-621 showed decrease or unchanged pre levels
respectively. Blocking of pre-miRNA processing and an increase in
the pre-miRNA levels is expected to result in decreased levels of
the mature miRNAs. However, the mature miRNA levels showed
variable tendencies. It is possible that each miRNA has its own
half-life and in the event that the miRNA are highly stable, they
will not degrade easily, and therefore their levels will remain
unchanged. In addition, blocking hnRNPH1 may result in slowing
of the miRNA processing but it might not completely arrest it,
therefore some miRNAs will still be processed. Over-expression of
hnRNPH1 did not show any significant changes in miRNA levels.
This might be explained by the fact that hnRNPH1 exists in
saturated levels in the cell and therefore over-expression does not
affect the miRNA processing. The binding experiment with
hnRNPH1 showed that there is a correlation between the binding
of hnRNPH1 to a certain pri-miRNA and the contribution of this
protein to miRNA processing, as implicated from the siRNA
experiment. MiRNAs that showed this tendency are miR-106b,
miR-25, miR-224, miR-196b, miR-21, miR-23b and miR-34a
(Fig. S4). These results support the hypotheses that hnRNPH1
affects miRNA processing through binding to pri-miRNAs.
Taken together these results support our hypothesis that
hnRNPR and hnRNPH1 exhibit a direct role in the processing
of pri-miRNAs. In addition we show for the first time that
hnRNPR exhibits an inhibitory activity whereas hnRNPH1
exhibits a facilitating role during miRNA processing. These
activities are presumably mediated by their binding to the pri-
miRNAs. In addition our results indicate that there is a great
versatility and variability in the processing of different miRNAs in
HeLa cells. This variability could stem from the involvement of
certain factors like hnRNPR and hnRNPH1 which might exhibit
different affinities to different pri or pre-miRNAs. The advantage
of regulation of specific miRNAs through their processing provides
the cell means to temporarily regulate the activity of the miRNAs
so that it would not reduce the levels of important targets
prematurely. The accumulation of pri/pre-miRNAs within the
cells enables the cell to respond rapidly when the miRNA is
needed. Therefore factors such as hnRNPH1 and hnRNPR might
be important to ensure correct pre- to mature miRNA ratio which
enables prompt response of the cell to different conditions.
In summary, we have shown for the first time that miRNAs
undergo differential processing within HeLa cells and responded
differently to different factors involved in miRNA biogenesis. Two
additional factors, hnRNPH1 and hnRNPR, were shown to
directly influence miRNA processing, either by inhibiting
(hnRNPR) or promoting (hnRNPH1) miRNA maturation of
certain miRNAs.
Supporting Information
Figure S1 GAPDH levels measured in cells expre-
ssing pcDNA3-hnRNPH1-Flag, pcDNA3-hnRNPR-Flag or
pcDNA3-Flag and immunoprecipitated using anti-Flag M2
beads.
(TIF)
Figure S2 Levels of pre (and pri) miRNAs in untreated
HeLa cells.
(TIF)
Figure S3 Fold change following siRNA of hnRNPR. Fold
change of pri-miRNAs in HeLa cells following siRNA against
hnRNPR and in correlation to the binding affinity of hnRNPR.
(TIF)
Figure S4 Fold change following siRNA of hnRNPH1.
Fold change of pri-miRNAs in HeLa cells following siRNA against
hnRNPH1 and in correlation to the binding affinity of hnRNPH1.
(TIF)
Table S1 The levels of mature and pre-miRNAs analyzed using
Quantitative/Real Time PCR. The pink colored miRNAs
represent miRNAs that exhibit high levels of mature miRNA
and low levels of pre-miRNAs. The blue colored miRNA
represents the miRNA that exhibit low levels of mature miRNA
and high levels of pre-miRNA.
(DOC)
Table S2 Fold change of pri-miRNAs in HeLa cells following
immunoprecipitation of either hnRNPH1 or hnRNPR. Fold
change is normalized to an empty pcDNA3-Flag vector.
(DOC)
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